CD4 and urinary bladder carcinoma: Additionally, a recent bladder cancer study showed that the tumor-specific gene expression program of cytotoxic GZMB+ CD4+ T cells treated with anti-PD-L1 therapy was marked by tumor overexpression of CXCL1353.